Trials / Sponsors / Precigen, Inc
Precigen, Inc
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cerv Cervical Cancer, HPV-Related Carcinoma, HPV-Related Malignancy | Phase 2 | 2025-03-21 |
| Recruiting | Zopa Retreatment and Vector Shedding in Adults With RRP Recurrent Respiratory Papillomatosis, Papillomavirus Infection, Papillomaviridae | Phase 4 | 2024-07-11 |
| Active Not Recruiting | Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis Recurrent Respiratory Papillomatosis, Papillomavirus Infections, Papillomaviridae | Phase 1 / Phase 2 | 2021-03-16 |
| Active Not Recruiting | PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher R Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2019-05-20 |
| Active Not Recruiting | Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistan Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma | Phase 1 | 2019-04-30 |